Revolutionize Your Cell Line Development Workflows
This white paper focuses on technologies used for developing clones for cell line development and demonstrates how to shorten the timeline from 2 to 3 months down to 1 month. It includes a discussion on current limitations and how to address them, including proof of clonality and inefficient workflows.
Key Highlights
- The demand for accelerated and audit-ready cell line development remains unmet in the biopharma community.
- Demonstrating clonality is crucial to ensure genomic homogeneity, consistent manufacturing, and safety of products.
- Single cell cloning using CellRaftA microscale polystyrene growth surface within an array used to spatially segregate cells/colonies while maintaining shared media access, enabling imaging over time and targeted isolation. Technology provides seamless cloning and images for proof of monoclonalityEvidence that a colony/line originated from one cell; often supported by time-course imaging and traceability..
- Traditional multimode platforms used in cell line development lead to increased costs and operational inefficiency, while CellRaft Technology aims to reduce time and increase efficiency and success rates.
Download the White Paper
Contact Us
Cell Microsystems
801 Capitola Drive, Ste 10
Durham, NC 27713
252.285.9842
Follow Us
© 2026 Cell Microsystems. All rights reserved.
Privacy Statement, Cookie Policy and Disclaimers.